Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker
- KO Validated
- Lab Essentials
- What is this?
5
(8 Reviews)
|
(66 Publications)
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) is a mouse monoclonal antibody detecting Cytokeratin 19 in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Over 50 publications
- Trusted since 2001
View Alternative Names
Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19
- IHC-P
AbReview19313****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
ab7754 staining Cytokeratin 19 in Human liver tissue sections by Immunohistochemistry (IHC-P - formaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 5% milk for 30 minutes at 37°C; antigen retrieval was by heat mediation in citrate buffer. Samples were incubated with primary antibody (1/1000 in antibody diluent) for 1 hour at 37°C. An undiluted HRP-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody.
This image is courtesy of an anonymous Abreview
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
Immunofluorescence analysis of 1 month hepato-differentiated Human dental pulp stem cells, staining Cytokeratin 19 with ab7754 at 1/60 dilution. A FITC-conjugated anti-mouse IgG was used as the secondary antibody.
Image from Ferro F et al., PLoS One. 2012;7(7):e41774. Epub 2012 Jul 23. Fig 3.; doi:10.1371/journal.pone.0041774; July 23, 2012, PLoS ONE 7(7): e41774.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
ab7754 staining Cytokeratin 19 in human skin.
Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control.
Sections were stained using an automated system (DAKO Autostainer Plus), at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate pH6.1. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
Immunohistochemical analysis of paraffin-embedded human liver tissue stained for Cytokeratin 19 using ab7754 at a 1/100 dilution followed by a GAM IgG-Alexa Fluor®488 diluted at 1/200 (green). Cell nuclei stained with PI (1 μg/ml; orange).
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
ICC/IF image of ab7754 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab7754 at 5μg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- mouse (ab96879) IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
- ICC
Lab
Immunocytochemistry - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
ab7754 staining Cytokeratin 19 in wild-type MCF7 cells (top panel) and KRT19 knockout MCF7 cells (bottom panel). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab7754 at 1/500 dilution and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
Overlay histogram showing MCF7 cells stained with ab7754 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab7754, 0.5μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2a [ICIGG2A] (ab91361, 1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
Separation of MCF-7 cells (red-filled) from human leukocytes (black-dashed) in flow cytometry analysis (intracellular staining) of peripheral whole blood spiked with MCF-7 cells stained using ab7754 (concentration in sample 3 μg/ml, GAM APC).
- WB
Supplier Data
Western blot - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (AB7754)
Western blotting analysis of human cytokeratin 19 using ab7754 at 2 μg/ml on lysates of HT-29 (Human colorectal adenocarcinoma cell line) cell line and Jurkat (Human T cell leukemia cell line from peripheral blood) cell line (cytokeratin non-expressing cell line; negative control) under non-reducing and reducing conditions.
IRDye800-conjugated anti-mouse IgG1 secondary antibody.
A specific band was detected for cytokeratin 19 at approximately 40 kDa.
All lanes:
Western blot - Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754)
Predicted band size: 44 kDa
false
Related conjugates and formulations (1)
-
519 FITC
FITC Anti-Cytokeratin 19 antibody [A53-B/A2]
Reactivity data
Product details
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.
What is the molecular weight of Cytokeratin 19?
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) specifically detects a band for Cytokeratin 19 (UniProt: P08727) at a molecular weight of 44kDa.
Trusted by the scientific community
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) was first used in a scientific publication in 2001 and has been cited over 50 times in peer-reviewed journals.
Reviewed by scientists
Anti-Cytokeratin 19 [A53-B/A2] - Cytoskeleton Marker (ab7754) has over 5 independent reviews from customers.
Specificity confirmed
The specificity of Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker (ab7754) has been confirmed by Immunocytochemistry testing in Cytokeratin 19 Knockout MCF7 cells.
Other related products
We have a range of other formats of antibody clone [A53-B/A2] also available for your convenience: ab7754, FITC - ab178543
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.
Pathways
CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (66)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1506 PubMed41044692
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells (Dayton, Ohio) 43: PubMed40574692
2025
Applications
Unspecified application
Species
Unspecified reactive species
BJC reports 3:35 PubMed40394379
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:8690 PubMed39375367
2024
Applications
Unspecified application
Species
Unspecified reactive species
Regenerative therapy 26:203-212 PubMed38948130
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38892168
2024
Applications
Unspecified application
Species
Unspecified reactive species
Breast cancer research : BCR 26:11 PubMed38229104
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 13:12261 PubMed37507439
2023
Applications
Unspecified application
Species
Unspecified reactive species
The American journal of pathology 193:1156-1169 PubMed37263345
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:861 PubMed36792623
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com